You are here

  • Home
  • Archive
  • Volume 65, Issue 12
  • Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography: a myocardial echostress scleroderma pattern

Article Text

Article menu
Download PDFPDF
Letter
Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography: a myocardial echostress scleroderma pattern
  1. A Vacca1,
  2. R Montisci2,
  3. A Cauli1,
  4. P Garau1,
  5. P Colonna2,
  6. M Ruscazio2,
  7. G Passiu1,
  8. L Meloni2,
  9. S Iliceto3,
  10. A Mathieu1
  1. 1IInd Chair of Rheumatology, Department of Medical Sciences, University of Cagliari, Cagliari, Italy
  2. 2Chair of Cardiovascular Diseases, Department of Cardiovascular and Neurological Sciences, University of Cagliari, Cagliari, Italy
  3. 3Cardiology Division, University of Padova, Padova, Italy
  1. Correspondence to:
    A Mathieu
    Cattedra di Reumatologia II, Dipartimento di Scienze Mediche, Policlinico Universitario SS 554, I-09042 Monserrato-Cagliari, Italy; mathieu{at}pacs.unica.it

http://dx.doi.org/10.1136/ard.2005.051110

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In this study, we investigate the possibility of detecting, by dobutamine stress echocardiography (DSE), the presence of early or subclinical myocardial functional changes in patients with systemic sclerosis (SSc) without symptoms of ischaemic cardiac involvement.

    Thirty consecutive patients with SSc (26 women and four men; mean age 51 years, range 28–73 years), with a mean disease duration of 8 years (range 1–21 years), were studied. In all, 16 of 30 patients with SSc were affected by diffuse cutaneous (dc)-SSc, and the remaining 14 patients had limited cutaneous (lc)-SSc. The study was approved by the local ethics committee, and all patients gave informed consent to participate. All patients fulfilled the American College of Rheumatology preliminary classification criteria for SSc.1 Table 1 lists the …

    View Full Text

    Footnotes

    • Competing interests: None declared.